The Allstate Corporation
NYSE:ALLInsurance - Property & Casualty
-$2.30 today
- Market cap
- $65.97B
- Beta
- 0.19
- P/E (TTM)
- 4.7
- EPS (TTM)
- $46.82
- Dividend yield
- 1.90%
Volume 1.38M
Average 1.52M
ALL Sales of Investments
Cash received from selling or redeeming investments.
The Allstate CorporationNYSE: ALL
Sales of Investments · Q2 FY2026 · quarter ended Jun 2026
Sales of investments turns positive
Q2 FY2026 sales of investments was $26.3B, compared with -$9.6B a year earlier. Trailing-twelve-month sales of investments was $50.97B. Over 3 fiscal years it compounded at +21.3% a year.
Context
- Sales of investments amounted to 121.5% of revenue in FY2025, up 51.5 pp from a year earlier.
- Sales of investments increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly sales of investments holds near $26.3B or moves back toward the trailing-twelve-month quarterly average of $12.74B.
Sources:Cash FlowText generated from reported figures; not investment advice.
Sales of Investments history
USD · from the cash flow
- Latest · FY2025
- 80.74B USD
- Year-over-year change
- +81.6%
- 4-year CAGR
- +16.0%
| Period | Period end | Sales of Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 80.74B | +81.6% |
| FY2024 | 2024-12-31 | 44.46B | +44.5% |
| FY2023 | 2023-12-31 | 30.76B | -32.0% |
| FY2022 | 2022-12-31 | 45.22B | +1.5% |
| FY2021 | 2021-12-31 | 44.54B | — |
Sales of Investments vs competitors
How ALL compares with its peers on the latest reported figures
- ALL's LTM Jun 2026 sales of investments of $50.97B is the largest of the 11 companies compared; the peer median is $2.16B.
- Its year-over-year change of +200.2% is the 3rd highest of 11, against a peer median of -43.6%.
- Sales of investments amounts to 73.7% of revenue for ALL, versus a peer median of 17.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $50.97B | +200.2% | +21.3% | 73.7% | |
| LTM Jun 2026 | $46.99B | +25.2% | +28.7% | 51.6% | |
| LTM Sep 2026 | $12.12B | +224.5% | -0.9% | 24.8% | |
| LTM Sep 2026 | $11.32B | -28.6% | +32.9% | 208.5% | |
| LTM Jun 2026 | $11.23B | -58.7% | -4.7% | 18.1% | |
| LTM Sep 2026 | $2.41B | -62.6% | -8.7% | 16.0% | |
| LTM Sep 2026 | $1.91B | -82.3% | -13.0% | 6.6% | |
| LTM Sep 2026 | $1.58B | +42.0% | +40.4% | 11.9% | |
| LTM Mar 2026 | $370.86M | +2071.1% | -58.9% | 29.2% | |
| LTM Jun 2026 | $348.6M | -111.0% | -60.1% | 5.2% | |
| LTM Sep 2026 | $322.87M | -69.2% | -9.0% | 16.6% | |
| Peer median (excluding ALL) | $2.16B | -43.6% | -6.7% | 17.4% | |
Competitors are the stored peer set for ALL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 1.57B | (1.36B) | (213M) | 4.6B | 10.28B |
| Depreciation & Amortization | 1.09B | 847M | 704M | 555M | 482M |
| Deferred Income Tax | (129M) | (102M) | 0 | 0 | 0 |
| Stock-Based Compensation | 129M | 102M | 0 | 0 | 136M |
| Change in Working Capital | (88M) | (53M) | 3.43B | 3.59B | (1.87B) |
| Accounts Receivables | (2.06B) | (630M) | (54M) | (931M) | (831M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | 1.98B | 577M | 3.48B | 4.52B | (1.04B) |
| Other Non-Cash Items | 2.55B | 5.69B | 309M | 188M | 1.08B |
| Operating Cash Flow | 5.12B | 5.12B | 4.23B | 8.93B | 10.11B |
| Capital Expenditures | (345M) | (420M) | (267M) | (210M) | (228M) |
| Acquisitions (Net) | (2.42B) | (288M) | (180M) | (814M) | 3.13B |
| Purchases of Investments | (41.91B) | (46.51B) | (33.28B) | (51.74B) | (90.78B) |
| Sales of Investments | 44.54B | 45.22B | 30.76B | 44.46B | 80.74B |
| Other Investing Activities | 639M | 268M | (37M) | 56M | (115M) |
| Investing Cash Flow | 510M | (1.73B) | (3B) | (8.25B) | (7.26B) |
| Debt Repayment | (436M) | 0 | (7M) | 145M | (600M) |
| Common Stock Issued | 114M | 0 | 0 | 0 | 48M |
| Common Stock Repurchased | (3.57B) | (2.52B) | (335M) | (2M) | (1.23B) |
| Dividends Paid | (999M) | (1.03B) | (1.03B) | (1.08B) | (1.15B) |
| Other Financing Activities | (349M) | 131M | 119M | 239M | 57M |
| Financing Cash Flow | (5.24B) | (3.42B) | (1.24B) | (697M) | (2.88B) |
| Effect of Forex Changes | 66M | 0 | 0 | 0 | 0 |
| Net Change in Cash | 452M | (27M) | (14M) | (18M) | (26M) |
| Free Cash Flow | 4.77B | 4.7B | 3.96B | 8.72B | 9.88B |
The Allstate Corporation
NYSE:ALL
Intrinsic Alpha fair value
Locked
Current Price
$266.59
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.